Please Wait...

Operational Metrics in Clinical Trials, Part 2

Performance Metrics Dashboard

Metrics defined by the Metrics Champion Consortium (MCC), a group of experts in clinical research, define how to measure the performance of our clinical trials and makes it easy to see where we are, and where we need to be in our study.

Since the metrics are the same for all clinical studies, we are comparing apples to apples.  We can see the number of subjects enrolled, completed, the number of open queries and entered pages.  We can see the data by study, by site, or pool site data from multiple studies.  Since we are using defined metrics, we know that the definition for ‘average time from CRF submission to verification’ is: Sum (CRF Verified Date - CRF Expected Date) / (Number of CRFs).  The definitions remain consistent across different clinical studies and programs.

Image: Example of dashboard showing performance metrics.

By setting targeted goals for each of our clinical trial metrics, we can start to generate indicators that tell us if we are within our target or not.

Let’s take our example in “The Use of Consistently Defined Clinical Trial Metrics - Part 1”: the number of days from a query response until the database is updated.  MCC defines this target as 2-3 days, but when using EDC, we may want to shorten that goal to one day.

We can easily create a dashboard to show the data, the metrics, and the performance indicator (green / yellow / red) telling us if we are within our target goal.  Pulling together all of this data in one place is the key to the successful use of clinical trial metrics.

The Only Way to Improve Clinical Trial Metrics Is to See Where We Are Outside Our Targets

This sounds very simple, and it is.  The challenge has always been measuring the same items in the same way for all studies.  The MCC has provided us with the standard clinical trial metrics that can be collected across the studies, individual users can provide their target goals, and all of the data can be shown using tools, such as SharePoint, and shared by all study team members.

By defining standard clinical trial metrics using operational data that is available for every study, and setting targets to show if we are on track, we can easily tell if our study is moving along smoothly and see which areas need some extra attention.

What types of clinical trial metrics do you think are important to collect for your studies?

Jennifer Price is on the MCC ‘Process Improvement Metrics Development Team.’

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (2 hours ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (Yesterday)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (Yesterday)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a… https://t.co/8ymd2Q9KcJ
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv… https://t.co/MpxTDV1T1L
bioclinica (Yesterday)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices